Surgalign Holdings, Inc. Announces Date Change for Fourth Quarter and Full Year 2020 Earnings Release and Conference Call
Surgalign Holdings, Inc. (Nasdaq: SRGA) announced a change in its earnings release date for the fourth quarter and full year 2020 due to delays in completing financial statements related to the OEM business sale. The new release date is set for March 16, 2021, post-market close. A conference call will follow at 4:30 p.m. ET, accessible via phone and webcast. Surgalign focuses on innovative spine care solutions, aiming to enhance surgical outcomes and improve patient lives.
- Surgalign is committed to innovative solutions in spine care, which could enhance market positioning.
- The company has a global presence, marketing products in over 50 countries.
- Delay in releasing financial results may raise concerns among investors regarding transparency.
- Ongoing classification of the OEM business as discontinued operations indicates potential operational challenges.
DEERFIELD, Ill., March 05, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, including through the application of digital technology, today announced that it is changing its earnings release and conference call date for the fourth quarter and full year 2020 as a result of a delay completing the financial statements related to the sale of the OEM business and its classification as discontinued operations. The Company now plans to release financial results from the fourth quarter and full year 2020 on Tuesday, March 16, 2021, after the close of trading.
Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (877) 383-7419 (U.S.) or (760) 666-3754 (International), using conference ID 1277107. The webcast can be accessed through the investor section of Surgalign’s website at surgalign.com/investors/. A replay of the conference call will be available on Surgalign’s website for at least one month following the call.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company is building off a legacy of high quality and differentiated products, and continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient’s lives. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign, a member of AdvaMed, is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Marquette, MI, and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.
Forward Looking Statement
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign's website at www.surgalign.com or the SEC's website at www.sec.gov.
Jonathon Singer
Investor and Media Contact
jsinger@surgalign.com
+1 877-343-6832
FAQ
When is Surgalign's earnings release for Q4 and full year 2020?
What caused the delay in Surgalign's financial results announcement?
How can I access Surgalign's conference call?
